← All articles

If a clinic offers to “optimize” your hormones with custom-compounded creams or pellets, here’s what you’re actually buying. “Bioidentical” is mostly marketing. The FDA-approved versions are the same molecules with real safety testing. Pellets carry risks the brochure won’t mention. Here’s how to spot the upsell.

Is “bioidentical” different from regular hormone therapy?

Not in the way the marketing claims. The word suggests natural, and therefore safer. But the estradiol and progesterone in compounded “bioidentical” products are the exact same molecules as in FDA-approved patches, gels, and capsules: plain estradiol and micronized progesterone, sold generically and as the combination capsule Bijuva.1 The safety difference is manufacturing and labeling: FDA-approved products are tested for consistent potency and carry formal risk labels; compounded versions do not.2 ACOG’s 2023 consensus states plainly that “bioidentical” is a marketing term used to imply a benefit that isn’t there.3

Decision table: the options are not equivalent

OptionWhat it isMain issueWhat I’d do
FDA-approved estradiol patch or gelBody-identical estradiol with regulated dosingStill needs the usual hormone-therapy risk screenThis is the standard, safer default
Micronized progesteroneBody-identical progesterone for people with a uterusNeeds the right dose to protect the uterine liningPair it with estrogen when indicated
Compounded cream or capsuleSame hormone idea, but pharmacy-made without FDA reviewPotency can run below or above labelAvoid when approved options exist
Hormone pelletLong-acting implant, often with high estrogen or testosterone levelsNo easy off-switch once insertedI would steer away
Saliva or repeated hormone panelsA dosing pitch dressed up as precisionNot validated for menopausal dosingDose to symptoms, not lab chasing

Compounded products: unknown dose, unknown safety

Compounded hormones skip FDA review. Two problems follow. First, dose is unreliable: when researchers tested compounded estradiol and progesterone from 13 pharmacies, potency ranged from about 26 percent below label to 31 percent above.4 With hormones, under-dosing can leave the uterine lining unprotected; over-dosing pushes levels too high. Second, there’s no package insert, no list of contraindications or warnings, which means you can’t really give informed consent.4 The safety evidence is thin: a 2022 review found trials short and built on surrogate markers, with no ability to judge breast cancer, uterine cancer, or heart risk.5 “No evidence of harm” here means those long-term outcomes have not been studied well enough, not that the products are safe.

What about hormone pellets?

Pellets, inserted under the skin every few months, are what I’d steer hardest away from. They release hormones at supraphysiologic levels: in one study of 539 women, peak estradiol averaged more than double the FDA-approved group and testosterone more than ten times higher, with some women hitting estradiol above 1,000 and testosterone above 400.6 The consequences tracked. About 58 percent had side effects versus 15 percent on FDA-approved therapy, abnormal bleeding was far more common, and the hysterectomy rate was triple.6 Once a pellet is in, it can’t be removed; you wait it out. ACOG specifically recommends against pellets for that exact combination of supraphysiologic dosing and no off-switch.3

The lab-testing pitch is the tell

A hallmark of these clinics is testing your hormone levels, often by saliva, then “customizing” your dose to hit a target. It sounds scientific, but it isn’t valid. Estrogen and progesterone don’t lend themselves to dosing-by-level the way a blood thinner does;1 saliva tests aren’t FDA-approved or reliable, and no guideline recommends hormone-level testing to set a menopausal dose.3 The right way to dose is to the lowest amount that controls your symptoms. Repeat panels every few months mostly generate a bill.

Where the bioidentical pitch can mislead

The underlying hormones aren’t the problem. Menopausal hormone therapy works and is reasonable for many women. The issue is the packaging: unregulated compounding, supraphysiologic pellets, and invalid testing. Testosterone belongs in this discussion because pellet clinics often sell it as part of the same “optimization” package. It has real, if modest, evidence for low sexual desire in postmenopausal women, but at physiologic doses through the skin, not pellets, and there’s no FDA-approved female product, so even that is off-label and needs honest counseling.7 “Optimizing” testosterone for energy or anti-aging is not evidence-based, and in women it risks acne, unwanted hair, and voice changes that may not fully reverse.7

Ask for FDA-approved estradiol and skip the upsell

If you want hormone therapy, ask about your FDA-approved body-identical options: an estradiol patch or gel, plus micronized progesterone if you still have a uterus. Same molecules, real testing, an actual label, and usually a fraction of the cost (often a few hundred dollars a year, frequently covered, versus a few thousand out of pocket at a clinic). Skip the pellets, skip the saliva panels, and treat “we’ll customize it to your levels” as a cue to leave. If a clinic sells you compounded hormones it also profits from, plus quarterly labs and pellet insertions, the incentives aren’t pointed at your health. The real version of this care is boring, well understood, and available from a regular doctor. For the bigger picture on whether hormones are right for you, see the perimenopause piece.